Clinical trial to evaluate the effect of a probiotic containing Lactobacillus Crispatus on the vaginal flora
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Enrollment
40
1 tablet / day of probiotic (275 mg of live probiotic lactic ferments: 10 Mld L. fermentum (SGL 10), 10 Mld L. gasseri, 10 Mld L. casei, 10 Mld L. acidophilus, 10 Mld L. crispatus) during 2 months.
Instituto Palacios
Madrid, Spain
Changes in the number of Lactobacillus Crispatus on the vaginal flora
Analysis of vaginal lactobacilli.
Time frame: Screening, month 2
Changes in vaginal PH
PH measurement
Time frame: Screening, month 2
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.